ClinicalTrials.Veeva

Menu

Bedside vs. Standard Microbiological Blood Culture Diagnostics - BEMIDIA Study

U

University Medicine Greifswald

Status

Unknown

Conditions

Sepsis Septic Shock

Treatments

Other: bedside blood culture

Study type

Observational

Funder types

Other

Identifiers

NCT03000049
SD_BK_1_ANI

Details and patient eligibility

About

With a completely bedside blood culture diagnostics system (BACTEC blood culture system in combination with the Accelerate ID/AST System) it is possible to optimize the initial antimicrobial therapy in patients with sepsis and septic shock.

Prospective observational, open-label mono-center study to compare a completely bedside blood culture diagnostics system (BACTEC blood culture system in combination with the Accelerate ID/AST System and Curetis Univero System) with standard blood culture diagnostics in patients with sepsis or septic shock.

Enrollment

500 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with a new diagnosed sepsis or septic shock: emergency department, operating theatre, intensive care unit and planed blood culture diagnostics.
  • informed written consent

Exclusion criteria

  • Pediatric patients (< 18 Years)
  • DNR-order

Trial contacts and locations

1

Loading...

Central trial contact

Matthias Gründling, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems